Knowledge (XXG)

Beilu Pharmaceutical

Source 📝

131: 668: 703: 760: 660: 219:
In 2014, Beilu Pharma invested 30 million yuan in Geneseeq Technology. In May 2016, it established an industry buyout fund worth 610 million yuan. In June, the company increased its investment in Geneseeq. Its
375: 791: 646: 358: 212:, and was financed by Infotech in 2008. It had reached required standards to float shares on the Shenzhen second board market in May 2009. In October, Beilu officially landed on the 806: 540: 569: 326: 519:"Diffusion-weighted MRI Enables to Accurately Grade Inflammatory Activity in Patients of Ileocolonic Crohn's Disease: Results from an Observational Study" 242: 621: 288:"Intra-Cavitary Contrast-Enhanced Ultrasound: A Novel Radiation-Free Method for Detecting Abscess-Associated Penetrating Disease in Crohn's Disease" 796: 786: 744: 463: 638: 345: 526: 480: 499: 151: 455: 287: 707: 413: 272: 353: 55: 147: 801: 143: 559: 584: 428: 202: 610: 481:"Radiological features combined with IDH1 status for predicting the survival outcome of glioblastoma patients" 522: 503: 484: 433: 291: 190: 65: 51: 182: 327:"An Analysis on the Concept of State-Owned Shares in Listed Companies and Their Obligation to Transfer" 588: 267: 518: 740: 730: 711: 592: 459: 449: 385: 617: 736: 380: 37: 243:"Exploring the path of healthcare collaboration: Beijing Beilu Pharmaceutical Company" 780: 45: 403: 262: 682: 305: 186: 500:"Radiomics and Ki-67 index predict survival in clear cell renal cell carcinoma" 765: 247: 221: 23: 715: 596: 389: 224:
surpassed 118 million yuan in 2017. In 2020, Beilu raised $ 70.42 million.
683:"Beilu Pharmaceutical to establish industry buyout fund worth 610 mln yuan" 661:"Geneseeq Technology Signs Investment Agreement with Beilu Pharmaceutical" 639:"Beilu Pharmaceutical Decides to End Its Agomelatine Development Project" 408: 687: 310: 213: 209: 83: 404:"Beilu Pharmaceutical Approved to List on the Shenzhen Stock Exchange" 346:"Impact of COVID-19 Pandemic on Pharmaceutical Manufacturing in China" 130: 564: 263:"DIGEMID Strengthens Regulations on Imported Pharmaceutical Products" 177:; short for Beijing Beilu Pharmaceutical Co., Ltd.), simply known as 585:"Investor volatility plagues drug companies on new Chinese exchange" 732:
The Competitiveness Report of Zhongguancun Listed Companies (2019)
140:
may have been created or edited in return for undisclosed payments
704:"China Precision Medicine Push Boosting Genomic Business Forays" 198: 112: 194: 124: 146:. It may require cleanup to comply with Knowledge (XXG)'s 107: 99: 89: 79: 71: 61: 43: 33: 21: 611:"Beyond Borders: Global Biotechnology Report 2010" 558:Vivian Wai-yin Kwok (Forbes Staff) (May 6, 2009). 517:Shomron Ben-Horin; Jian Zhang (January 11, 2017). 761:"China Diagnostic Imaging Market Outlook to 2025" 286:Jordi Rimola; Zhirong Zeng (December 13, 2018). 792:Companies listed on the Shenzhen Stock Exchange 306:"Beilu Pharmaceutical receives GMP certificate" 583:Peter Mitchell and Fu Jing (January 1, 2010). 429:"UBS China Looks to Smaller Firms for Growth" 8: 16: 325:Wang Weidong; Jean Zhang (August 6, 2013). 15: 807:Manufacturing companies based in Beijing 498:Yuanwei Liu; Ying Ming (July 10, 2023). 479:Jun Ma; Tao Jiang (September 25, 2015). 216:under the ticker symbol "SHE: 300016". 671:from the original on December 11, 2023. 649:from the original on December 11, 2023. 627:from the original on December 13, 2023. 529:from the original on December 13, 2023. 416:from the original on December 13, 2023. 376:"Hong Kong stocks close 0.69% stronger" 364:from the original on December 11, 2023. 275:from the original on December 13, 2023. 233: 197:. Prior to that, it was listed on the 17:Beijing Beilu Pharmaceutical Co., Ltd. 7: 541:"Beilu Pharma Raises 67 Million RMB" 203:gadopentetate dimeglumine injections 448:Jiazhuo G. Wang; Juan Yang (2016). 142:, a violation of Knowledge (XXG)'s 14: 572:from the original on May 9, 2009. 208:Beilu Pharma is headquartered in 427:Chao Deng (September 12, 2012). 129: 702:Ying Huang (October 19, 2016). 560:"The Nasdaq of China is Coming" 344:Portia Liang (June 12, 2022). 241:Ramay, Ali (August 12, 2023). 201:. The company mainly produces 1: 797:Companies established in 1992 787:2009 initial public offerings 354:Center for Global Development 451:Financing without Bank Loans 193:in 2009 and underwritten by 205:, and Iohexol injections. 95:China, Pakistan, Peru, etc. 823: 523:Oxford University Press 504:Oxford University Press 485:Oxford University Press 434:The Wall Street Journal 292:Oxford University Press 191:Shenzhen Stock Exchange 103:Jiuwei Zhenxin Granules 271:. September 30, 2013. 183:pharmaceutical company 175:Beilu Pharmaceuticals 152:neutral point of view 589:Nature Biotechnology 314:. December 29, 2016. 185:founded in 1992. It 171:Beilu Pharmaceutical 802:1992 establishments 667:. August 26, 2014. 18: 620:. April 28, 2010. 547:. August 26, 2008. 412:. August 6, 2009. 173:(alternatively as 746:978-981-15-1648-1 691:. April 28, 2016. 645:. July 19, 2011. 618:Ernst & Young 465:978-981-10-0901-3 168: 167: 123: 122: 814: 771: 770: 769:. June 30, 2020. 757: 751: 750: 726: 720: 719: 699: 693: 692: 679: 673: 672: 657: 651: 650: 635: 629: 628: 626: 615: 607: 601: 600: 580: 574: 573: 555: 549: 548: 537: 531: 530: 514: 508: 507: 495: 489: 488: 476: 470: 469: 445: 439: 438: 424: 418: 417: 400: 394: 393: 384:. June 3, 2015. 372: 366: 365: 363: 350: 341: 335: 334: 322: 316: 315: 302: 296: 295: 283: 277: 276: 259: 253: 252: 238: 163: 160: 148:content policies 133: 125: 119: 116: 114: 19: 822: 821: 817: 816: 815: 813: 812: 811: 777: 776: 775: 774: 759: 758: 754: 747: 739:. p. 286. 728: 727: 723: 701: 700: 696: 681: 680: 676: 659: 658: 654: 637: 636: 632: 624: 613: 609: 608: 604: 582: 581: 577: 557: 556: 552: 539: 538: 534: 516: 515: 511: 497: 496: 492: 478: 477: 473: 466: 458:. p. 143. 447: 446: 442: 426: 425: 421: 402: 401: 397: 374: 373: 369: 361: 348: 343: 342: 338: 324: 323: 319: 304: 303: 299: 285: 284: 280: 261: 260: 256: 240: 239: 235: 230: 181:, is a Chinese 164: 158: 155: 150:, particularly 134: 111: 92: 48: 26: 12: 11: 5: 820: 818: 810: 809: 804: 799: 794: 789: 779: 778: 773: 772: 752: 745: 721: 694: 674: 665:MarketScreener 652: 630: 602: 575: 550: 532: 509: 490: 471: 464: 440: 419: 395: 381:The Australian 367: 336: 317: 297: 278: 254: 232: 231: 229: 226: 166: 165: 137: 135: 128: 121: 120: 109: 105: 104: 101: 97: 96: 93: 90: 87: 86: 81: 77: 76: 73: 69: 68: 66:Pharmaceutical 63: 59: 58: 49: 44: 41: 40: 35: 31: 30: 27: 22: 13: 10: 9: 6: 4: 3: 2: 819: 808: 805: 803: 800: 798: 795: 793: 790: 788: 785: 784: 782: 768: 767: 762: 756: 753: 748: 742: 738: 734: 733: 729:ZLCA (2019). 725: 722: 717: 713: 709: 705: 698: 695: 690: 689: 684: 678: 675: 670: 666: 662: 656: 653: 648: 644: 640: 634: 631: 623: 619: 612: 606: 603: 598: 594: 590: 586: 579: 576: 571: 567: 566: 561: 554: 551: 546: 542: 536: 533: 528: 524: 520: 513: 510: 505: 501: 494: 491: 486: 482: 475: 472: 467: 461: 457: 453: 452: 444: 441: 436: 435: 430: 423: 420: 415: 411: 410: 405: 399: 396: 391: 387: 383: 382: 377: 371: 368: 360: 356: 355: 347: 340: 337: 332: 328: 321: 318: 313: 312: 307: 301: 298: 293: 289: 282: 279: 274: 270: 269: 264: 258: 255: 250: 249: 244: 237: 234: 227: 225: 223: 217: 215: 211: 206: 204: 200: 196: 192: 188: 184: 180: 176: 172: 162: 159:February 2024 153: 149: 145: 141: 138:This article 136: 132: 127: 126: 118: 110: 106: 102: 98: 94: 88: 85: 82: 78: 74: 70: 67: 64: 60: 57: 53: 50: 47: 42: 39: 36: 32: 28: 25: 20: 764: 755: 731: 724: 697: 686: 677: 664: 655: 642: 633: 605: 578: 563: 553: 544: 535: 512: 493: 474: 450: 443: 432: 422: 407: 398: 379: 370: 352: 339: 331:Lexology.com 330: 320: 309: 300: 281: 266: 257: 246: 236: 218: 207: 178: 174: 170: 169: 156: 144:terms of use 139: 115:.beilupharma 80:Headquarters 34:Company type 29:Beilu Pharma 187:went public 91:Area served 781:Categories 766:GlobalData 248:24 Digital 228:References 222:net profit 24:Trade name 716:0143-7690 597:1087-0156 390:1038-8761 46:Traded as 737:Springer 669:Archived 647:Archived 643:BioSpace 622:Archived 570:Archived 545:BioSpace 527:Archived 456:Springer 414:Archived 409:Interfax 359:Archived 273:Archived 100:Products 62:Industry 688:Reuters 311:Reuters 214:ChiNext 210:Beijing 189:on the 108:Website 84:Beijing 72:Founded 743:  714:  595:  565:Forbes 462:  388:  268:Andina 56:300016 38:Public 708:Scrip 625:(PDF) 614:(PDF) 362:(PDF) 349:(PDF) 179:Beilu 741:ISBN 712:ISSN 593:ISSN 460:ISBN 386:ISSN 199:NEEQ 117:.com 75:1992 52:SZSE 195:UBS 154:. 113:www 783:: 763:. 735:. 710:. 706:. 685:. 663:. 641:. 616:. 591:. 587:. 568:. 562:. 543:. 525:. 521:. 502:. 483:. 454:. 431:. 406:. 378:. 357:. 351:. 329:. 308:. 290:. 265:. 245:. 54:: 749:. 718:. 599:. 506:. 487:. 468:. 437:. 392:. 333:. 294:. 251:. 161:) 157:(

Index

Trade name
Public
Traded as
SZSE
300016
Pharmaceutical
Beijing
www.beilupharma.com

terms of use
content policies
neutral point of view
pharmaceutical company
went public
Shenzhen Stock Exchange
UBS
NEEQ
gadopentetate dimeglumine injections
Beijing
ChiNext
net profit
"Exploring the path of healthcare collaboration: Beijing Beilu Pharmaceutical Company"
24 Digital
"DIGEMID Strengthens Regulations on Imported Pharmaceutical Products"
Andina
Archived
"Intra-Cavitary Contrast-Enhanced Ultrasound: A Novel Radiation-Free Method for Detecting Abscess-Associated Penetrating Disease in Crohn's Disease"
Oxford University Press
"Beilu Pharmaceutical receives GMP certificate"
Reuters

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.